CLINICAL_TRIALS
trial_result
· 2013-12-12
Clinical Trial Update: Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis [Phase 2]
Summary
A Phase 2 trial evaluating safety and pharmacokinetics of alefacept in adolescent patients with moderate to severe psoriasis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Psoriasis | Phase 2 | Status: COMPLETED